For the first International Finance Facility for Immunisation debt issue to succeed, lead managers Goldman Sachs and Deutsche Bank had to devise a way of frontloading development finance at an affordable cost. Edward Russell-Walling reports on a scheme designed to ensure reliable funding for vaccine projects.